PPIDT00410

Drug Information
NameSomatrogon
SequenceSSSSKAPPPSLPSPSRLPGPSDTPILPQFPTIPLSRLFDNAMLRAHRLHQLAFDTYQEFEEAYIPKEQKYSFLQNPQTSLCFSESIPTPSNREETQQKSNLELLRISLLLIQSWLEPVQFLRSVFANSLVYGASDSNVYDLLKDLEEGIQTLMGRLEDGSPRTGQIFKQTYSKFDTNSHNDDALLKNYGLLYCFRKDMDKVETFLRIVQCRSVEGSCGFSSSSKAPPPSLPSPSRLPGPSDTPILPQSSSSKAPPPSLPSPSRLPGPSDTPILPQ
DrugBank_IDDB14960
Typebiotech
IndicationSomatrogon is indicated for the long-term treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone (growth hormone deficiency).[L39362,L47153]
Dosage Forms
Form Route Strength
Injection, solution Subcutaneous
24 mg/1.2mL
Injection, solution Subcutaneous
60 mg/1.2mL
Solution Subcutaneous
20 mg / mL
Solution Subcutaneous
50 mg / mL
Target Information
Role Uniprot_ID Gene_Name Entity_Name Organism Actions Internal link
target P10912 GHR Growth hormone receptor Homo sapiens binder Link